Cardinal Health Inc. (NYSE:CAH) went up by 0.48% from its latest closing price compared to the recent 1-year high of $60.69. The company’s stock price has collected -2.38% of loss in the last five trading sessions. Press Release reported on 09/25/20 that Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2021 on November 5
Is It Worth Investing in Cardinal Health Inc. (NYSE :CAH) Right Now?
Plus, the 36-month beta value for CAH is at 0.95. Opinions of the stock are interesting as 3 analysts out of 17 who provided ratings for Cardinal Health Inc. declared the stock was a “buy,” while 2 rated the stock as “overweight,” 11 rated it as “hold,” and 1 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $59.20, which is $12.33 above the current price. CAH currently public float of 291.91M and currently shorts hold a 1.35% ratio of that float. Today, the average trading volume of CAH was 2.29M shares.
CAH’s Market Performance
CAH stocks went down by -2.38% for the week, with a monthly drop of -9.20% and a quarterly performance of -10.51%, while its annual performance rate touched 1.07%. The volatility ratio for the week stands at 2.58% while the volatility levels for the past 30 days are set at 2.76% for Cardinal Health Inc.. The simple moving average for the period of the last 20 days is -2.67% for CAH stocks with a simple moving average of -10.17% for the last 200 days.
Analysts’ Opinion of CAH
Many brokerage firms have already submitted their reports for CAH stocks, with Deutsche Bank repeating the rating for CAH by listing it as a “Buy.” The predicted price for CAH in the upcoming period, according to Deutsche Bank is $61 based on the research report published on September 25th of the current year 2020.
UBS gave a rating of “Buy” to CAH, setting the target price at $64 in the report published on May 15th of the current year.
CAH Trading at -9.30% from the 50-Day Moving Average
After a stumble in the market that brought CAH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.71% of loss for the given period.
Volatility was left at 2.76%, however, over the last 30 days, the volatility rate increased by 2.58%, as shares sank -7.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.13% lower at present.
During the last 5 trading sessions, CAH fell by -2.38%, which changed the moving average for the period of 200-days by -10.22% in comparison to the 20-day moving average, which settled at $47.38. In addition, Cardinal Health Inc. saw -8.46% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CAH
Current profitability levels for the company are sitting at:
- +1.16 for the present operating margin
- +4.15 for the gross margin
The net margin for Cardinal Health Inc. stands at -2.42. The total capital return value is set at 15.24, while invested capital returns managed to touch -32.42. Equity return is now at value -302.30, with -9.10 for asset returns.
Based on Cardinal Health Inc. (CAH), the company’s capital structure generated 403.58 points at debt to equity in total, while total debt to capital is 80.14. Total debt to assets is 17.71, with long-term debt to equity ratio resting at 397.21. Finally, the long-term debt to capital ratio is 78.88.
Currently, EBITDA for the company is 555.00M with total debt to EBITDA at 2.51. When we switch over and look at the enterprise to sales, we see a ratio of 0.13, with the company’s debt to enterprise value settled at 0.37. The receivables turnover for the company is 18.27 and the total asset turnover is 3.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.10.